However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
It makes everything from medications for hormone replacement therapy to fertility treatments and popular anti-aging injections, such as nicotinamide adenine dinucleotide, or NAD+
Approved in April 2026, Foundayo provides maximum dosing flexibility, requiring no water restrictions or specific timing
Effects of nine weeks L-carnitine supplementation on exercise performance, anaerobic power, and exercise-induced oxidative stress in resistance-trained males
and the function of pH-sensitive excipients such as buffers and preservatives
This may reduce the intended benefits of the treatment